KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabre (SABR) Cash & Equivalents (2016 - 2025)

Sabre's Cash & Equivalents history spans 13 years, with the latest figure at $791.6 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 9.26% year-over-year to $791.6 million; the TTM value through Dec 2025 reached $791.6 million, up 9.26%, while the annual FY2025 figure was $791.6 million, 9.26% up from the prior year.
  • Cash & Equivalents reached $791.6 million in Q4 2025 per SABR's latest filing, up from $661.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.3 billion in Q1 2021 to a low of $426.1 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $804.1 million, with a median of $753.6 million recorded in 2022.
  • The largest YoY upside for Cash & Equivalents was 87.72% in 2021 against a maximum downside of 38.64% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $978.4 million in 2021, then dropped by 18.75% to $794.9 million in 2022, then decreased by 18.45% to $648.2 million in 2023, then grew by 11.77% to $724.5 million in 2024, then increased by 9.26% to $791.6 million in 2025.
  • Per Business Quant, the three most recent readings for SABR's Cash & Equivalents are $791.6 million (Q4 2025), $661.7 million (Q3 2025), and $426.1 million (Q2 2025).